INTRODUCTION
The human erythrocyte membrane contains four predominant sialoglycoproteins (denoted a, /3, y and d; Anstee et al., 1979) . Although the most abundant of these (a and d) have been extensively studied, their function is, as yet, unknown. In contrast, there is substantial evidence for the involvement of / and y in maintaining the shape of the human erythrocyte. Both / and y are associated with the skeleton of normal erythrocytes. Mueller & Morrison (1981) found that /3 was absent from skeletons prepared from the erythrocyte membranes of a patient with hereditary elliptocytosis with band-4. 1 deficiency. They suggested that the cytoplasmic portion of / provides a membrane attachment site for the skeleton through band 4.1. This suggestion has been supported by the finding of five individuals from three apparently unrelated kindred with elliptocytosis whose erythrocyte membranes lack /3, y and a minor component denoted fl, (Anstee et al., 1984a; Daniels et al., 1986) . The erythrocytes of these latter individuals lack the very common Gerbich (Ge) antigen(s) and are described as 'Leach phenotype' (Anstee et al., 1984b) . Two other erythrocyte types which also lack the Ge antigen have been described (Ge type and Yus type), and membranes derived from these erythrocytes also apparently lack , and y. However, the membranes of both these types possess abnormal sialoglycoprotein molecules and the erythrocytes have normal shape (Anstee et al., 1984b) . We have suggested that these abnormal sialoglycoprotein molecules are hybrid molecules with their N-terminus derived from , and their C-terminus derived from y and that they function in place of /8 and y in these cells.
In the experiments reported here we have used rabbit antisera which react with sialoglycoproteins / and y-toconfirm the absence of / and y from Ge-negative erythrocytes and to show that the cytoplasmic portion of ,/, y and the abnormal components of Ge-type and Yus-type erythrocytes are structurally related; we also show that the abnormal components are more extensively N-glycosylated than is normal /. In addition, we demonstrate that the extramembranous portion of y is immunologically distinct from that of /.
MATERIALS AND METHODS
Murine monoclonal anti-,/ (BRIC 10) antibody was as described by Anstee et al. (1984a,b) . The twenty different human anti-Ge sera were gifts from a variety of sources, as were erythrocyte samples from Ge-negative donors of the Ge type and the Yus type. SDS/polyacrylamide-gel Vol. 244
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electrophoresis of erythrocyte membranes was carried out on gels containing 100% acrylamide with a 30% -acrylamide overlay using the method of Laemmli (1970) . Immunoblotting was as described by Mallinson et al. (1986) , except that 500 (w/v) bovine milk powder was used as the blocking agent. When human antisera were used, their binding was detected by using peroxidaseconjugated rabbit and goat anti-human IgG (Dako Ltd., High Wycombe, Bucks., U.K., or Bio-Rad, Richmond, CA, U.S.A.). The binding of rabbit antisera was detected by using the biotin-streptavidin-peroxidase system supplied by Amersham International, Amersham, Bucks., U.K. The production and use of endo-,/-galactosidase (Flavobacterium keratolyticus) and Endo F preparations (Flavobacterium meningosepticum; Elder & Alexander, 1982) has been described in detail elsewhere (Tanner et al., 1987) . Immunoprecipitation was performed using ghosts prepared from erythrocytes labelled by the periodate/NaB3H4 method. Briefly, 1 vol. of intact erythrocytes was labelled with periodate/NaB3H4 (Gahmberg & Andersson, 1977) and ghosts prepared. Antibody preparations were incubated with labelled ghosts for 60 min on ice. The ghosts were then washed with 7 mM-sodium phosphate buffer, pH 7.4, before addition of 6 vol. of 10 Triton X-100/PBS (pH 7. Dodge et al. (1963) . The ghosts were then extracted with 5 or 6 vol. of 0.10% Triton X-l00/ ImM-DTT/l mM-EDTA/1 mm-PMSF at pH 7.4 on ice for 15 min (Owens et al., 1980) . The pellet obtained after centrifugation at 30000 g for 30 min at 4°C was washed twice in 7 mM-sodium phosphate buffer/1 mM-DTT/1 mM-EDTA/1 mM-PMSF, pH 7.4, and the sialoglycoproteins extracted as described by Anstee & Tanner (1974) . Briefly, the pellet was suspended in ice-cold 20 mM-sodium phosphate buffer/I mM-PMSF pH 7.0 (50 ml), mixed and incubated on ice for 5 min. An equal volume of ice-cold n-butanol was added, the whole vigorously shaken and then incubated on ice for 15 min. After centrifugation at 25000 g for 10 min at 4 'C, the aqueous phase was recovered, dialysed exhaustively against distilled water and freeze-dried. Aliquots of the freeze-dried material were dissolved in 50 mM-Tris/HCI containing 150 mM-NaCl, 0.5% LDAO (Fluka, Germany) and 1 mM-PMSF, pH 7.0, and applied to an affinity column comprising murine monoclonal anti-, antibody bound to Sepharose equilibrated in the same buffer. Elution of bound material was achieved with 50 mM-triethylamine/ 0.5 00 LDAO/1 mM-PMSF, pH 11.0. The eluted material was immediately collected into 1 M-Tris/HCl, pH 7.4, dialysed extensively against distilled water and freezedried. The material not retained by the column was used as a y-rich preparation in haemagglutination-inhibition assays.
Preparation of rabbit antisera to p1 and the abnormal component from Ge-negative erythrocytes of the Gerbich type Antibodies were produced in rabbits by the protocol described previously (Mawby et al., 1981) . The rabbits were bled 10 days after the third and subsequent subcutaneous injections, the serum separated and heated to 56°C for 30 min. To remove those antibodies specific for the extracellular portion of,/ and/or y, the rabbit sera were absorbed with normal intact erythrocytes until no haemagglutinin (direct or indirect) activity remained. This serum was dialysed against PBS, pH 7.4, and the IgG fraction was purified on a Protein A-Sepharose column (Langone, 1982) . Absence of haemagglutinating activity against intact human erythrocytes was confirmed on the final preparations.
RESULTS AND DISCUSSION
Ii, /J1, y and the abnormal sialoglycoprotein components of Gerbich (Ge) negative erythrocytes are structurally related Rabbit antisera were produced to purified normal , and 3 , S (serum E) and to the purified abnormal component of Ge-negative erythrocytes of the Ge type (serum G) as described in the Materials and methods section. Each rabbit serum was absorbed with intact human erythrocytes to remove antibody activity to the extracellular surface and the post-absorption serum used in immunoprecipitation experiments with erythrocyte ghosts prepared from periodate/NaB3H4-labelled erythrocytes. Antibodies directed against Ge-related antigens may be found in the serum of Ge-negative individuals as naturally occurring antibodies or as antibodies produced in response to pregnancy or transfusion. Anti-Ge antibodies in individuals with normal Ge antigens (auto-anti-Ge antibodies) have also been described (for a review, see Reid, 1986) . The specificity of the human anti-Ge antibodies was analysed by immunoblotting. In all, 19 different human serum samples containing antiGe and one containing auto-anti-Ge were studied. All these antisera reacted with sialoglycoprotein y (see, e.g., Fig. 1) . A reactive band of Mr 54000-56000 was also observed on the immunoblots, which may correspond to dimers of y (Fig. 1) . Four of the antisera, including the auto-antibody, also reacted with fi, but none reacted with / alone. Three of these antisera (which reacted with both fi and y) also reacted with the abnormal component of Yus-type Ge-negative erythrocytes. The auto-antibody was one of these. The other antiserum (R.W., from Ms. V. Vengelen-Tyler, American Red Cross, Los Angeles, CA, U.S.A.), which reacted with both f8 and y, was unusual in that it was obtained from serum of an individual whose erythrocytes apparently contained the abnormal Yus-type component. This abnormal component in the erythrocytes of this individual may, therefore, be different from the usual component found in most Yus-type erythrocytes. None of those antisera which reacted with y alone also reacted with the abnormal sialoglycoprotein of Yus-type erythrocyte membranes. In haemagglutination-inhibition assays, the sera which reacted with y alone using immunoblotting were also shown to be inhibited by a y-rich sialoglycoprotein preparation, but not by purified , (results not shown). Since these sera react specifically with the extracellular portion of y, this region of y contains an epitope not present on ,.
The experiment shown in Fig. 2 was carried out to determine if those antisera which recognize both fi and y react with an epitope common to the extracellular portion of the two sialoglycoproteins. Normal erythrocyte ghosts were subjected to SDS/polyacrylamide-gel electrophoresis, the separated components electrophoretically transferred to nitrocellulose and incubated with human anti-Ge serum (44017). The antibody molecules bound to the regions corresponding to , and y were separately eluted and their reactivity towards , and y determined by immunoblotting normal erythrocyte ghosts. The eluate recovered from the , region reacted with both , and y (Fig. 2d) . The eluate recovered from the y region also reacted with both , and y (Fig. 2f) .
Neither of the eluted antibodies reacted with immunoblots of Leach-phenotype ghosts (which lack both /8 and y; Figs. 2c and 2e). As a control, a portion of nitrocellulose from a region containing components of Mr 15000-25000 was subjected to the same procedure; the eluted material showed no reactivity with normal erythrocyte ghosts (Fig. 2h) . This result demonstrates that the extracellular portions of I, and y share a common epitope.
All the human anti-Ge sera failed to react with anti-fl activity of the sera reacting with both ft and y is not dependent on the presence of an N-glycosidically linked oligosaccharide. The abnormal sialoglycoproteins of Ge-negative erythrocytes have unusual N-glycans We have previously reported (Reid et al., 1985; Tanner et al., 1987) that both ft and y are unaffected when intact erythrocytes are treated with endo-,8-galactosidase and that treatment with Endo F results in a decrease in the Mr of a proportion of f molecules by about 3500 while y remains unaffected. The observed decrease in the Mr of f on Endo F treatment is consistent with the known presence of an N-glycosidically linked oligosaccharide on this molecule (Dahr et al., 1982) . The resistance to endo-f,-galactosidase suggests that repeated N-acetyllactosamine-containing units are absent from ft.
The abnormal sialoglycoprotein components present in membranes from Ge-negative erythrocytes of the Ge type and the Yus type give much broader bands on SDS/polyacrylamide-gel electrophoresis than do normal ft and y (Anstee et al., 1984b) . The possibility that these broader bands result from heterogenous glycosylation was investigated by using endo-,8-galactosidase and Endo F treatment of intact erythrocytes with subsequent SDS/polyacrylamide-gel electrophoresis on the isolated membranes and immunoblotting using a murine monoclonal anti-ft antibody (BRIC 10) which has previously been shown to react with the abnormal components present in both these cell types (Anstee et al., 1984b) . When small amounts of ghosts were applied to the gels, the broad bands corresponding to the abnormal components of Ge-type and Yus-type Ge-negative cells were resolved into a series of distinct bands ranging from Mr 27000 to 35000 for Ge-type cells and Mr 29000-36000 for Yus-type cells (Fig. 3) . After treatment with endo-,-galactosidase, the relative intensity of staining of these bands was altered. In Ge-type cells the leading edge of the band (Mr 27000-28000) was increased in staining intensity. In Yus-type cells the leading edge of the band (Mr 29000-30000) became more prominent. As expected, f of normal cells was unaffected by this treatment (Fig. 3h) . These results suggest that polylactosamine groups are present on the abnormal sialoglycoprotein components and absent from normal ft. When the cells were treated with Endo F, a new lower-Mr (24000-25500) band appeared in Ge-negative cells of the Ge type, whereas a new band of Mr 26000-27000 appeared in Ge-negative cells of the Yus type. Identical treatment of normal erythrocytes resulted in the expected decrease in the Mr of a proportion of the normal f band from Mr 36500-38000 to Mr 34000-34500 (Fig. 3) . In order to exclude the possibility of a general abnormality in the N-glycosylation of cell-surface glycoproteins in Ge-negative erythrocytes, immunoblotting with murine monoclonal antibody R1.3 (which specifically binds a and d; Tanner et al., 1987) was used to show that, under the conditions used, Endo F decreased the Mr of a by about 3000 in normal erythrocytes and in all three Ge-negative phenotypes (Leach, Ge and Yus) . This confirms that the N-glycosidically linked oligosaccharide of normal a is of similar size in normal and all three types of Ge-negative cells (results not shown). These results strongly suggest thatthe abnormal sialoglycoproteins found in Ge-negative erythrocytes of the Ge and Yus types have an increased content of N-glycosidically linked oligosaccharide(s). These abnormal sialoglycoproteins also contain a proportion of polylactosamine units, and it is likely that heterogeneity in the content of these units gives rise to the broad band found on gel electrophoresis. A contribute to the diffuse migration of erythrocyte band 3 on SDS/polyacrylamide gels (Mueller et al., 1979) . Evidence is accumulating that the conformation of the polypeptide backbone influences oligosaccharide processing (reviewed by Kornfeld & Kornfeld, 1985) . It is possible that this increased glycosylation of the abnormal components results from altered oligosaccharide processing, because of differences in the conformation of the polypeptides resulting from structural differences between these abnormal components and normal f,.
In the present study we have used antibodies to probe the structural relationships between fi, y and the abnormal sialoglycoproteins found in some Ge-negative erythrocytes. The results presented here clearly show that portions of both the cytoplasmic and extracellular regions of ft and y are structurally related, since they share epitopes. However, the results also demonstrate that the extracellular regions of these molecules are antigenically different, since most human anti-Ge sera are specific for y. Further, monoclonal anti-,f antibodies (BRIC 4 and BRIC 10) do not react with y, but do react with the abnormal sialoglycoprotein components of Geand Yus-type Ge-negative erythrocytes, demonstrating that the extracellular portions of these abnormal components are structurally related to f (Anstee et al., 1984b; Figs. 2 and 3) . Since the abnormal components do not react with most human anti-Ge sera, they lack the antigenic determinants present on the extracellular portion of y which react with these antibodies. However, the reactivity of three anti-Ge sera with fi, y and the abnormal component of Ge-negative erythrocytes of the Yus type may indicate the presence of an extracellular epitope common to all these molecules. It is possible that these abnormal components are hybrid molecules with the N-terminus derived from f and the C-terminus derived from y. f,t y and the abnormal components are all associated with the erythrocyte skeleton, and this may impose structural constraints on the cytoplasmic portions of these molecules which might make them antigenically similar. Our inability to demonstrate antigenic differences between the cytoplasmic portions of f and y means that, although these data are not inconsistent with the hypothesis that the abnormal components are hybrid f,-y molecules, they do not provide formal proof that this is the case. Amino acid sequence information will be required to establish the structure of the abnormal sialoglycoproteins. 
